Novartis Pharmaceuticals UK Ltd.
Novartis is a world leader in offering innovation–driven, patent–protected medicines to patients and physicians.
Our mission is to discover, develop and successfully market innovative products to prevent diseases, to ease suffering and to enhance the quality of life. Novartis Oncology has a strong heritage in cancer care and endocrinology.
Sandoz is a Novartis company with a vision to dramatically increase worldwide patient access to essential high-quality biopharmaceuticals, by consistently advancing our global leadership position in follow-on biologics. In April 2006, the EMA approved the world’s first biosimilar medicinal product – Omnitrope – a recombinant human growth hormone made by Sandoz.
ONC13-C005 February 2013
For more information on Novartis, visit our website at www.novartis.co.uk/.